AVEVV Framework Series - VULNERABILITY (TRUST)
VULNERABILITY (TRUST)
The Scientist Who Almost Lost a Clinical Trial.
The Senior Director of Clinical Research at a mid-size biotech company in Rockville, MD had spent fifteen years being the smartest person in every room she entered.
She had never needed to admit she did not know something. She had never been wrong about anything that mattered. And her team had learned, quietly and thoroughly, never to challenge her.
That silence nearly cost the company a Phase II trial.
What Vulnerability Actually Means
Vulnerability in a leadership context is not therapy. It is not sharing feelings. It is the specific, operational condition that determines whether a team will surface a problem before it becomes a crisis — or carry it quietly until it cannot be contained.
Amy Edmondson's foundational research at Harvard Business School established psychological safety as the primary driver of team learning and performance across industries, organization sizes, and roles. Google's two-year Project Aristotle study confirmed it: psychological safety was the single strongest predictor of team performance — outranking individual talent, team composition, seniority, and structure combined.
The mechanism is simple and consequential: teams where members feel safe speaking up surface problems early. Teams where they do not suppress them until the exposure is unavoidable.
For a biotech company running clinical trials under FDA scrutiny, the stakes of that suppression are not abstract.
What Changed
The Senior Director's AVEVV engagement began with two questions she had never been asked in a professional context: When was the last time you told your team you were uncertain? Do your direct reports feel confident enough to express their concerns if something is not going well?
The first answer - Never.
The second answer - No.
The work was not about manufacturing humility she did not feel. It was about building specific, repeatable behaviors — asking genuine questions before offering answers, acknowledging the boundaries of her own certainty in team meetings, responding to dissent with curiosity rather than authority — that created the operating conditions where her team could function at full capacity. It was about creating TRUST.
Daily Performance Continuum directives between sessions targeted the specific moments where her default was to close down rather than open up — pre-meeting preparation, post-meeting reflection, one-on-one cadences with direct reports.
Over the twelve-month engagement:
Problem-surfacing frequency increased — issues raised early enough to correct without escalation or rework, compared to baseline
Psychological safety measured through employee survey scores within her team improved 64% — moving from the bottom third to the top quartile within the organization
Two FDA submission timelines were accelerated because the team began surfacing early-stage concerns that the Director was now equipped to receive without shutting the conversation down
One direct report who had been quietly managing an undisclosed accommodation need disclosed early in month four — eight months earlier, she had considered resigning instead
Team attrition dropped to zero over the twelve-month period — in an industry where voluntary turnover among clinical research professionals runs 20–25% annually
The thing she had been protecting against — looking uncertain, appearing fallible, needing to “have answers” — had been the source of nearly every problem that had accumulated under her leadership. When she stopped protecting it, the team stopped hiding things.
AVEVV's Vulnerability pillar builds the operating conditions where high-performing teams can actually function — and where every team member, including those with undisclosed disabilities, can contribute fully.
[Schedule a Discovery Call → avevv.com]